Cargando…

Immune Network Receives First Impact Factor of 2.524

Detalles Bibliográficos
Autor principal:	Lee, Chong-Kil
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Association of Immunologists 2018
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6117509/ https://www.ncbi.nlm.nih.gov/pubmed/30181916 http://dx.doi.org/10.4110/in.2018.18.e28

Ejemplares similares

Partial Characterization of an Anti-Listerial Bacteriocin from Enterococcus faecium CJNU 2524
por: Yang, Jung-Mo, et al.
Publicado: (2021)

Fatigue Fracture Analysis on 2524 Aluminum Alloy with the Influence of Creep-Aging Forming Processes
por: Ma, Liyong, et al.
Publicado: (2022)

Diagnostics Receives First Impact Factor
por: Kjaer, Andreas
Publicado: (2019)

Immune Network Selected for Science Citation Index Expanded
por: Lee, Chong-Kil
Publicado: (2017)

2524. Prevalence and Associated Factors of Seroprotection Against Japanese Encephalitis Virus Among HIV-Infected Thai Adolescents Stable on Combination Antiretroviral Treatment
por: Sudjaritruk, Tavitiya, et al.
Publicado: (2019)

Séminaire Bourbaki : exposés 507–524
por: Dold, A, et al.
Publicado: (1979)

524 Reccurent Wheezing in Childhood—Is It Always Asthma?
por: Muti, Andrea Daniela, et al.
Publicado: (2012)

524 Traveling Pediatric Burn Care on Wheels
por: Pruitt, Mary, et al.
Publicado: (2023)

Comparaison de la jauge NRC 524
por: Dubler, H
Publicado: (1969)

ERJ Open Research receives its first impact factor and plans for the next step
por: Song, Woo-Jung, et al.
Publicado: (2023)

Abstract No. : ABS2524 : Preventive strategies in chronic persistent postsurgical pain following breast cancer Surgery- A systematic review and meta-analysis,
por: Khushboo,
Publicado: (2022)

Annals of Geriatric Medicine and Research receives the First Impact Factor of 3.6 by Journal Citation Reports
por: Lim, Jae-Young
Publicado: (2023)

2524. Safety and Pharmacokinetics of PA-001, a New Potential COVID-19 Drug That Targets the S2 Subunit of SARS-CoV-2 Spike Protein, in Healthy Subjects
por: Kurasaki, Haruaki, et al.
Publicado: (2023)

POS-524 MORTALITY AMONG NEW HAEMODIALYSIS PATIENTS IN THE FIRST SIX MONTHS OF COVID-19 PANDEMIC
por: HAZARA, A., et al.
Publicado: (2021)

The draft genome of Corchorus olitorius cv. JRO-524 (Navin)
por: Sarkar, Debabrata, et al.
Publicado: (2017)

Correction to Lancet Diabetes Endocrinol 2017; 5: 524–33
Publicado: (2017)

Journal of Stroke (JoS) Receives High Impact Factor
por: Kim, Jong S.
Publicado: (2016)

JTE: first Impact Factor of 2.683
por: Knowles, Jonathan, et al.
Publicado: (2018)

IS524: Coulomb excitation of neutron-rich odd-A Cd isotopes
por: Kröll, Thorsten
Publicado: (2015)

Adiciones al Artículo 524 del Código de procedimientos civiles
por: Garduza Gómez, Elda Ligia
Publicado: (1998)

Journal of Educational Evaluation for Health Professions received the Journal Impact Factor, 4.4 for the first time on June 28, 2023
por: Huh, Sun
Publicado: (2023)

Molecular Cytogenetics: the first impact factor (2.36)
por: Liehr, Thomas, et al.
Publicado: (2013)

PB2524: TRIAL IN PROGRESS: THE HIBISCUS-KIDS STUDY, A SINGLE-ARM, OPEN-LABEL, PHASE 1/2 STUDY TO EVALUATE THE PHARMACOKINETICS AND SAFETY OF ETAVOPIVAT IN PEDIATRIC PATIENTS WITH SICKLE CELL DISEASE
por: Colombatti, Raffaella, et al.
Publicado: (2023)

SAT-524 Re-hospitalization And Mortality Outcome Following Atypical Femur Fracture
por: Yang, Betsy, et al.
Publicado: (2019)

miR-524-5p suppresses the growth of oncogenic BRAF melanoma by targeting BRAF and ERK2
por: Liu, Szu-Mam, et al.
Publicado: (2014)

The Non-Anhydrous, Minimally Basic Synthesis of the Dopamine D(2) Agonist [18F]MCL-524
por: Inkster, James A. H., et al.
Publicado: (2021)

FRI524 Improving The Quality Of Life In Patients With Not Adequately Treated Hypothyroidism: The Impact Of Comprehensive Thyroid Care For Hypothyroid Patients
por: Högqvist Tabor, Vedrana, et al.
Publicado: (2023)

MicroRNA-524 promotes cell proliferation by down-regulating PTEN expression in osteosarcoma
por: Zhuang, Ming, et al.
Publicado: (2018)

Mice with RyR1 mutation (Y524S) undergo hypermetabolic response to simvastatin
por: Knoblauch, Mark, et al.
Publicado: (2013)

miR-524-5p reduces the progression of the BRAF inhibitor-resistant melanoma
por: Nguyen, Mai-Huong Thi, et al.
Publicado: (2020)

ODP524 Thyroid Storm Precipitated by COVID-19 Infection: A Case Report
por: Veeramachaneni, Ravali, et al.
Publicado: (2022)

SAT524 Relaxin: A Novel Marker for Pro-Tumoral Thyroid Cancer Microenvironment?
por: Kotwal, Anupam, et al.
Publicado: (2023)

P524: PHARMACODYNAMICALLY DEFINED METRONOMIC DOSING OF DECITABINE AND VENETOCLAX IN ACUTE MYELOID LEUKEMIA
por: Fedorov, Kateryna, et al.
Publicado: (2023)

The First Impact Factor - Journal of Intensive Care
por: Morisaki, Hiroshi
Publicado: (2020)

PM524. VEGF may have a neuroprotective role in the improvement of schizophrenia or in the treatment effects of antipsychotics
por: Kim, Yongku, et al.
Publicado: (2016)

XP-524 is a dual-BET/EP300 inhibitor that represses oncogenic KRAS and potentiates immune checkpoint inhibition in pancreatic cancer
por: Principe, Daniel R., et al.
Publicado: (2022)

Testing the Neuroprotective Properties of PCSO-524(®) Using a Neuronal Cell Cycle Suppression Assay
por: Zhu, Beika, et al.
Publicado: (2019)

The effectiveness of marine based fatty acid compound (PCSO-524) and firocoxib in the treatment of canine osteoarthritis
por: Vijarnsorn, Monchanok, et al.
Publicado: (2019)

524 How Can I Provide My Patient Insights in a Nontraditional Advocacy Role?
por: Kerensky, Max, et al.
Publicado: (2022)

524. Hepatic Safety of Remdesivir Across Phase 3 Placebo-controlled COVID-19 Studies
por: Force, Lindsey, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_m50js81p6t59bjn16bsn4snueb